Publication: Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Seung, Kwonjune J., Molly Franke, and Stephen W. Linton. 2016. “Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?” PLoS Medicine 13 (8): e1002062. doi:10.1371/journal.pmed.1002062. http://dx.doi.org/10.1371/journal.pmed.1002062.
Research Data
Abstract
Kwonjune Seung and colleagues describe the Eugene Bell Foundation's experience of treating MDR-TB in North Korea.
Description
Other Available Sources
Keywords
Medicine and Health Sciences, Infectious Diseases, Bacterial Diseases, Tuberculosis, Tropical Diseases, People and places, Geographical locations, Asia, North Korea, Extensively Drug-Resistant Tuberculosis, Pharmaceutics, Drug Therapy, Diagnostic Medicine, Tuberculosis Diagnosis and Management, People and Places, Population Groupings, Ethnicities, Korean People, Pharmacology, Drugs, Isoniazid, Government Laboratories
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service